002365 logo

Qianjiang Yongan Pharmaceutical Co., Ltd. Stock Price

SZSE:002365 Community·CN¥4.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002365 Share Price Performance

CN¥14.93
6.51 (77.32%)
CN¥14.93
6.51 (77.32%)
Price CN¥14.93

002365 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

3 Risks
1 Reward

Qianjiang Yongan Pharmaceutical Co., Ltd. Key Details

CN¥797.2m

Revenue

CN¥679.7m

Cost of Revenue

CN¥117.6m

Gross Profit

CN¥92.2m

Other Expenses

CN¥25.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.088
14.75%
3.19%
1.4%
View Full Analysis

About 002365

Founded
2001
Employees
930
CEO
Rengui Hong
WebsiteView website
www.chinataurine.com

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China.

Recent 002365 News & Updates

Recent updates

No updates